The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysis
Standard
The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysis. / Modemann, Franziska; Ahmadi, Paymon; von Kroge, Philipp H; Weidemann, Sören; Bokemeyer, Carsten; Dierlamm, Judith; Fiedler, Walter; Ghandili, Susanne.
in: LEUKEMIA LYMPHOMA, Jahrgang 64, Nr. 11, 08.08.2023, S. 1801-1810.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysis
AU - Modemann, Franziska
AU - Ahmadi, Paymon
AU - von Kroge, Philipp H
AU - Weidemann, Sören
AU - Bokemeyer, Carsten
AU - Dierlamm, Judith
AU - Fiedler, Walter
AU - Ghandili, Susanne
PY - 2023/8/8
Y1 - 2023/8/8
N2 - Patients with primary gastrointestinal (GI) lymphoma are at risk of GI perforations. Therefore, we aimed to investigate the prognostic impact of non-traumatic GI perforations. 54 patients with a histologically confirmed diagnosis of primary GI lymphoma were included. Non-traumatic lymphoma perforation occurred in ten patients (19%). Perforations occurred only in patients with aggressive B-cell lymphoma. In patients with aggressive B-cell lymphoma, the median overall survival (mOS) was 52 months (95% CI 9.88-94.12) and 27 months (95% CI 0.00-135.48) in patients with and without GI perforation, respectively. The median progression-free survival (mPFS) was 30 months (95% CI 5.6-54.4) in patients with GI perforations. In patients without lymphoma perforation, mPFS was not reached. Both mOS and mPFS did not significantly differ. In conclusion, despite the need for emergency surgery and delay in lymphoma-directed treatment, lymphoma perforation did not negatively impact our study population's OS or PFS.
AB - Patients with primary gastrointestinal (GI) lymphoma are at risk of GI perforations. Therefore, we aimed to investigate the prognostic impact of non-traumatic GI perforations. 54 patients with a histologically confirmed diagnosis of primary GI lymphoma were included. Non-traumatic lymphoma perforation occurred in ten patients (19%). Perforations occurred only in patients with aggressive B-cell lymphoma. In patients with aggressive B-cell lymphoma, the median overall survival (mOS) was 52 months (95% CI 9.88-94.12) and 27 months (95% CI 0.00-135.48) in patients with and without GI perforation, respectively. The median progression-free survival (mPFS) was 30 months (95% CI 5.6-54.4) in patients with GI perforations. In patients without lymphoma perforation, mPFS was not reached. Both mOS and mPFS did not significantly differ. In conclusion, despite the need for emergency surgery and delay in lymphoma-directed treatment, lymphoma perforation did not negatively impact our study population's OS or PFS.
U2 - 10.1080/10428194.2023.2240921
DO - 10.1080/10428194.2023.2240921
M3 - SCORING: Journal article
C2 - 37552203
VL - 64
SP - 1801
EP - 1810
JO - LEUKEMIA LYMPHOMA
JF - LEUKEMIA LYMPHOMA
SN - 1042-8194
IS - 11
ER -